Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 412-600-3 | CAS number: 152827-98-0
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.76 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 375
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- exposure based waiving
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 7.84 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1 500
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- exposure based waiving
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The substance is of low acute toxicity following oral administration and dermal application, with no mortality or signs of systemic toxicity observed at the limit dose of 2000 mg/kg bw in both studies. No signs of skin irritation were observed following dermal application in rabbits while only very minimal and transient irritation (redness of the conjunctiva of degree 1 at the one hour reading) was observed follwoing instillation into the eye, with or without washing the eye after instillation. No sensitisation potential was demonstrated in a fully compliant Local Lymph Node Assay, up to and including a 50 % concentration in acetone/olive oil (4:1 v/v).
Negative results were obtained for two endpoints of in-vitro genotoxicity i.e. gene mutation in bacterial cells and clastogenicity in mammalian (CHO) cells and on this basis the substance is considered not to possess any genotoxic potential.
In a fully compliant repeated-dose 28-day dietary study in rats, inclusive of evaluation of neurotoxicity endpoints (i.e. functional observation battery and motor activity assessment), the registered substance did not evoke any systemic toxicity as evidenced by the lack of any effects on body weights and/or food consumption, clinical signs, haematological and clinical chemistry parameters, organ weight and histopathology, as well as abnormalities at FOB and motor activity assessment. The NOAEL of the study was set at 15 ppm, the highest dose level tested, which corresponds to mean achieved intakes higher than the limit dose of 1000 mg/kg bw/day for repeat-dose studies (i.e. 1176 mg/kg bw/day in males and 1247 mg/kg bw/day in females). This endpoint has been chosen as the starting point for DNEL calculations. Although reproductive toxicity studies are waived on the basis of lack of human exposure through the manufacturing process and use of the photographic paper in line with the column 2 adaptation specified in point 8.7.1, Annex VIII of Regulation 1907/2006, an additional assessment factor of 5 has been used for quality of the data base as a highly precautionary measure.
Based on the physical-chemical properties of the substance (i.e. molecular weight >500, log Pow >4) a default dermal absorption value of 10 % is considered appropriate for the derivation of the long-term dermal DNEL.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.68 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 750
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- exposure based waiving
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.92 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 3 000
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- exposure based waiving
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.39 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 3 000
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The same toxicological endpoint chosen for setting the DNELs for workers was chosen for setting the DNELs for the general population. The increased assessment factor for interspecies sensitivity is considered adequately protective.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
